|Dataset||HPO Gene-Disease Associations|
|Category||disease or phenotype associations|
|Description||A type of megaloblastic anemia that improves upon administration of pyrimidine supplements such as uridylic acid and cytidylic acid. (Human Phenotype Ontology, HP_0003339)|
|Downloads & Tools|
1 genes associated with the pyrimidine-responsive megaloblastic anemia phenotype by mapping known disease genes to disease phenotypes from the HPO Gene-Disease Associations dataset.
|UMPS||uridine monophosphate synthetase|